Therapeutic anti-VEGF in age-related macular degeneration: Ranibizumab and Bevacizumab controversy.
S Flores
SF
Moreno
J Bautista
JB
Paloma
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D000069579:Ranibizumab; D042442:Vascular Endothelial Growth Factors / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042442:Vascular Endothelial Growth Factors; D000068258:Bevacizumab; D000069579:Ranibizumab